Archive

Your Voice Matters: Help Transfer Cannabis out of Schedule I

By Shawn Hauser
May 29, 2024

We are at a historic and critical moment for cannabis reform, as the DOJ and HHS/FDA have proposed rescheduling cannabis to Schedule III. The DEA is accepting public comments until July 22, 2024 via the Federal eRulemaking Portal, so now is the time to take action and make your voice heard!

Cannabis Rescheduling: The DEA's Proposed Rule and the Supporting OLC Opinion

By Jason Adelstone
May 21, 2024

The DEA published its proposed rule to move marijuana from schedule I to schedule III on May 21, and the 60-day public comment period has officially opened. The DEA also published an opinion from the Office of Legal counsel that provides a thorough analysis supporting why placing marijuana in schedule III is appropriate and legally justified. Read this insight for a high-level overview of the proposed rule and the OLC Opinion.

Marijuana Rescheduling Part II: Why Opponents Continue to Have No Idea What They Are Talking About

By Jason Adelstone
May 20, 2024

In a recent House Committee meeting with DEA Administrator Anne Milgram, Rep. Andrew S. Clyde voiced his opposition to removing marijuana from Schedule I based on public safety reasons, but then contradicted himself by stating marijuana is “not as dangerous as some of the others we have talked about” (the meeting focused primarily on fentanyl’s harms to communities). This blog post addresses the false narratives and misconceptions that opponents of cannabis reform continue to promote.

Marijuana Rescheduling: Why Opponents Have No Idea What They Are Talking About

By Jason Adelstone
Apr 29, 2024

After listening to the House Oversight and Accountability Committee Hearing with the Commissioner of the FDA on April 11, one conclusion was reinforced—opponents of marijuana reform are misinformed and rely on misstating facts to support their position. Those against moving marijuana into schedule III are making their voices heard, but almost universally, those voices simply do not understand what schedule III would mean.

The Massachusetts Cannabis Social Equity Trust Fund: What You Need to Know

By David M. Ullian
Feb 13, 2024

Massachusetts launched the Cannabis Social Equity Trust Fund to aid qualified cannabis businesses disproportionately impacted by marijuana prohibition. Licensed businesses or applicants meeting specific criteria, like Social Equity Program participants, can access grants or loans (up to $50,000 now!). Apply online and learn more about future programs before the February 15th deadline.

New Funding Opportunity for Maryland’s Social Equity Cannabis Business Applicants

By Meg Nash, Bridgette Nikisher
Feb 7, 2024

Maryland's Cannabis Business Assistance Loan/Grant Fund is offering grants to help social equity applicants cover costs associated with obtaining a cannabis business license. The program reimburses up to 50% of eligible expenses, with a maximum of $5,000. Applications open February 19th and close March 20th. Read this Insights post to learn more about eligibility, qualifying expenses, and how to apply.

The DEA’s Scheduling of Marijuana: What Happens After the DEA Publishes Its Rule?

By Jason Adelstone
Jan 30, 2024

On August 29, 2023, the Department of Health and Human Services (“HHS”) sent the Drug Enforcement Administration (“DEA”) its recommendation to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (“CSA”). Since then, the marijuana industry has waited in suspense for the DEA to make the final call as to what schedule marijuana will be placed. Read this Insights post that outlines the complex process of marijuana rescheduling in the US and outlines the key steps involved, from rule publication to review and final rule, emphasizing the critical role of stakeholder engagement in securing a Schedule III classification.

[Webinar] Michigan Cannabis Market Trends & Economic Forecast

Oct 11, 2023

Watch this live session on Wednesday, October 11 at 1 p.m. ET. The session will feature Vicente LLP’s director of economics and research, Andrew Livingston, and the firm’s Michigan practice leader, Travis Copenhaver, as they discuss Michigan cannabis market trends and opportunities that will help your business to better adapt, strategize, and navigate changing market conditions.

Cannabis and Hemp Developments in North Carolina

By David M. Ullian, Gabriel Amatruda
Oct 5, 2023

Public support for medical cannabis in North Carolina is quite strong and despite being one of only a few states that have legalized medical or adult use, cannabis is finally making headway in the Tar Heel State. Read this article to learn about recent cannabis and hemp developments in NC, including legislation and the Eastern Band of Cherokee Indians’ vote to legalize adult-use cannabis.

President Biden's Cannabis Scheduling Directive: Part 3

By Shane Pennington
Nov 9, 2022

What outcomes are possible from the impending administrative process to reconsider cannabis’s schedule I status? What are the implications of those various possible outcomes? And how should we all proceed in light of it all?

How to Fix Non-compliant Michigan Cannabis Product Packaging

By Krissy Atterholt
Oct 28, 2022

Complying with Michigan's marijuana packaging and labeling laws can be challenging to navigate if you don't pay close attention to the rules. If a product's packaging is not compliant, some potential remedies are available to bring the product back into compliance.

Michigan Cannabis Packaging and Labeling 101

By Krissy Atterholt
Oct 28, 2022

Cannabis packaging and labeling requirements vary across markets and product types, so it’s critical that your packaging and labeling are compliant with state-specific regulations. Read this article to know what information needs to be on marijuana product packaging in Michigan.

President Biden's Cannabis Scheduling Directive: Part 2

By Shane Pennington
Oct 21, 2022

To appreciate the gravity of the President’s scheduling directive and what could happen next, you need to understand (1) how the administrative process the President has set in motion will actually work and (2) how the agencies in charge have used it to affirm and reaffirm cannabis’s schedule I1 status repeatedly throughout the Comprehensive Drug Abuse Prevention and Control Act of 1970’s (“CSA”) history. Those topics are covered in this article. 

Can't-miss Cannabis Business Opportunities in New and Growing Markets

By Jerrico Perez
Aug 21, 2020

Vicente Sedeberberg LLP continues to identify exclusive licensing opportunities for our clients. With more winning merit-based applications than any other law firm in the country, our team’s work ethic, dedication, and experience can help elevate your application above the competition.

Cannabis Business Licensing Opportunities Amidst COVID-19

By Jerrico Perez
May 13, 2020

Vicente Sedeberberg LLP continues to identify exclusive licensing opportunities for our clients. With more winning merit-based applications than any other law firm in the country, our team’s work ethic, dedication, and experience can help elevate your application above the competition.